AD-signature region cerebral glucose metabolism

Biomarker

1 paper2 findings

  • Humans1

Interventions

2

Decreasing body mass index

downin humans1

1 study
  1. Decreasing body mass index decreases AD-signature region cerebral glucose metabolism in humans (β = 0.029; 95% CI, 0.003 to 0.055; p = .027).

    “Participants with decreasing BMI patterns from midlife to late life exhibited significantly lower AD-CM compared to those with increasing patterns (β = 0.029; 95% CI, 0.003 to 0.055; p = .027).”

    Humansnon-demented older adults, decreasing vs increasing patternsbrainn = 268

    BMI changes from midlife to late life and their relationship with Alzheimer's disease pathologies

    Alzheimer's research & therapy23 Jan 2026

More on Decreasing body mass index

Midlife body mass index

downin humans1

1 study
  1. Midlife body mass index decreases AD-signature region cerebral glucose metabolism in humans (β = − 0.009; 95% CI, − 0.015 to − 0.003; p < .01).

    “Higher midlife BMI correlated significantly with lower AD-CM (β = − 0.009; 95% CI, − 0.015 to − 0.003; p < .01).”

    Humansnon-demented older adultsbrainn = 268

    BMI changes from midlife to late life and their relationship with Alzheimer's disease pathologies

    Alzheimer's research & therapy23 Jan 2026

More on Midlife body mass index

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months